Department of Cancer Nanotechnology, United States
Mini Review
Biomarkers, bioinformatics, and nanotechnology coming together to create individualized cancer treatment
Author(s): Joseph Michael*
Biomarker disclosure, Biocomputing, and nanotechnology have raised new open doors for the arising field of customized
medication in which sickness identification, analysis, and treatment are custom-made to every individual's sub-atomic
profile, and furthermore for prescient medication that utilizes hereditary sub-atomic data to anticipate illness advancement,
movement, and clinical result. Multiplexed nanoparticle probes for cancer biomarker profiling and advanced Biocomputing
tools for cancer biomarker discovery are the topics of this article, as are the opportunities and challenges associated with tying
bio molecular signatures to clinical outcomes. For personalized treatment and molecular diagnosis of cancer and other human
diseases, this convergence of bio-nano-information holds great promise.
Keywords
Biomarker disclosure; Biocomputing; Nanotec.. View more»